Medical supervision remains advisable
It may be that a discussion is needed to explore other potential causes for the symptoms or to re-evaluate the patients current treatment plan, but an early injection might not be the standard solution
Based on the work of Professor Khavinson and his research team, the International Peptide Society has published the following sample epithalon dosing protocol for anti-aging purposes (the Russian Protocol) [26]: Total Dosage: 100mg epithalon Frequency: Administer 10mg of epithalon daily, in one to two subcutaneous injections
While it is not a first-choice treatment, it can benefit patients who do not respond well to acid suppression alone
Selling it without a prescriber evaluating the patient removes every safety guardrail that makes this medication acceptably safe
Future research needs to define dose ranges, combination strategies, and subgroups most likely to benefit